Patent · US Active

Rho kinase inhibitors

US8093266B2 · kind B2 · utility

5Cited by

0References

11Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Georg Dahmann · Biberach an der Riß, DE
Eugene Richard Hickey · Danbury, US
Xiang Li · Beijing, CN
Wang Mao · Milford, US
Daniel Richard Marshall · Tucson, US
Tina Morwick · New Milford, US
Robert Sibley · North Haven, US
Roger John Snow · Danbury, US
Ronald John Sorcek · Bethel, US
Frank Wu · Shandong, CN
Erick Richard Roush Young · Danbury, US

Key dates

Filing date	Jan 2, 2008
Grant date	Jan 10, 2012
Priority date	—
Expiry date	Aug 4, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Substituted amide and urea derivatives useful as inhibitors of Rho kinase are described, which inhibitors can be useful in the treatment of various disorders such as cardiovascular diseases, cancer, neurological diseases, renal diseases, bronchial asthma, erectile dysfunction and glaucoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.